How to control an infectious bead string: Nucleosome-based regulation and targeting of herpesvirus chromatin

Reviews in Medical Virology

Volumn 21, Issue 3, 2011, Pages 154-180

  Nevels, Michael ^a   Nitzsche, Alexandra ^a   Paulus, Christina ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AZACITIDINE; CHAPERONE; CURCUMIN; DOUBLE STRANDED DNA; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; PARGYLINE; TRANYLCYPROMINE; VIRUS DNA; VORINOSTAT;

CHROMATIN; CUTANEOUS T CELL LYMPHOMA; EPIGENETICS; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HERPES VIRUS INFECTION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE PHOSPHORYLATION; HUMAN; HUMAN CYTOMEGALOVIRUS; MYELODYSPLASTIC SYNDROME; NONHUMAN; NUCLEOSOME; REVIEW; VIRION; VIRUS GENOME; VIRUS NUCLEOCAPSID;

CHROMATIN; CYTOMEGALOVIRUS; DNA, VIRAL; HERPESVIRUS 1, HUMAN; HISTONES; HUMANS; MODELS, BIOLOGICAL; NUCLEOSOMES; VIRUS ACTIVATION; VIRUS LATENCY; VIRUS REPLICATION;

EID: 79955391412     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.690     Document Type: Review

References (266)

1. Davison A. Overview of classification. In Human Herpesviruses-Biology, Therapy, and Immunoprophylaxis, Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, and Yamanishi K (eds). Cambridge University Press: Cambridge, 2007; 3-9.
2. Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK. Murine model of cytomegalovirus latency and reactivation. Current Topics in Microbiology and Immunology 2008; 325: 315-331.
3. Stevenson PG, Simas JP, Efstathiou S. Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4. The Journal of General Virology 2009; 90: 2317-2330.
4. Ensser A. Simian gammaherpesviruses. In Encyclopedia of Virology, Mahy BWJ, van Regenmortel MHV (eds). Elsevier: Oxford, 2008; 589-594.
5. Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Current Topics in Microbiology and Immunology 2008; 325: 63-83.
6. Mocarski ES, Shenk T, Pass RF. Cytomegaloviruses. In Fields Virology, Knipe DM, Howley PM, Griffin DE, Lamb RA, Straus SE, Martin MA, Roizman B (eds). Lippincott Williams and Wilkins: Philadelphia, 2007; 2701-2773.
7. Goodrum F, Jordan CT, Terhune SS, High K, Shenk T. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations. Blood 2004; 104: 687-695.
8. Goodrum FD, Jordan CT, High K, Shenk T. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 16255-16260.
9. Kondo K, Xu J, Mocarski ES. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 11137-11142.
10. Kondo K, Kaneshima H, Mocarski ES. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proceedings of the National Academy of Sciences of the United States of America 1994; 91: 11879-11883.
11. Minton EJ, Tysoe C, Sinclair JH, Sissons JG. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. Journal of Virology 1994; 68: 4017-4021.
12. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. The Journal of General Virology 1991; 72: 2059-2064.
13. Sinclair J. Human cytomegalovirus: latency and reactivation in the myeloid lineage. Journal of Clinical Virology 2008; 41: 180-185.
14. Reeves M, Sinclair J. Aspects of human cytomegalovirus latency and reactivation. Current Topics in Microbiology and Immunology 2008; 325: 297-313.
15. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 1987; 235: 1056-1059.
16. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In Fields Virology, Knipe DM, Howley PM, Griffin DE, Lamb RA, Straus SE, Martin MA, Roizman B (eds). Lippincott Williams and Wilkins: Philadelphia, 2007; 2501-2601.
17. Lieberman P, Hu J, Renne R. Gammaherpesvirus maintenance and replication during latency. In Human Herpesviruses - Biology, Therapy, and Immunoprophylaxis, Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, and Yamanishi K (eds). Cambridge University Press: Cambridge, 2007; 379-402.
18. Kenney S. Reactivation and lytic replication of EBV. In Human Herpesviruses - Biology, Therapy, and Immunoprophylaxis, Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, and Yamanishi K (eds). Cambridge University Press: Cambridge, 2007; 403-433.
19. Allis CD, Jenuwein T, Reinberg D. Overview and concepts. In Epigenetics, Allis CD, Jenuwein T, Reinberg D, Caparros M-L (eds). Cold Spring Harbor Laboratory Press: New York, 2007; 23.
20. Gibney ER, Nolan CM. Epigenetics and gene expression. Heredity 2010; 105: 4-13.
21. Lu X, Triezenberg SJ. Chromatin assembly on herpes simplex virus genomes during lytic infection. Biochimica et Biophysica Acta 2010; 1799: 217-222.
22. Kutluay SB, Triezenberg SJ. Role of chromatin during herpesvirus infections. Biochimica et Biophysica Acta 2009; 1790: 456-466.
23. Knipe DM, Cliffe A. Chromatin control of herpes simplex virus lytic and latent infection. Nature Reviews. Microbiology 2008; 6: 211-221.
24. Lieberman PM. Chromatin organization and virus gene expression. Journal of Cellular Physiology 2008; 216: 295-302.
25. Placek BJ, Berger SL. Chromatin dynamics during herpes simplex virus-1 lytic infection. Biochimica et Biophysica Acta 2010; 1799: 223-227.
26. Takacs M, Banati F, Koroknai A, et al. Epigenetic regulation of latent Epstein-Barr virus promoters. Biochimica et Biophysica Acta 2010; 1799: 228-235.
27. Ingvarsdottir K, Blaho JA. Role of viral chromatin structure in the regulation of herpes simplex virus 1 gene expression and replication. Future Microbiology 2009; 4: 703-712.
28. Sinclair J. Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochimica et Biophysica Acta 2010; 1799: 286-295.
29. Paulus C, Nitzsche A, Nevels M. Chromatinisation of herpesvirus genomes. Reviews in Medical Virology 2010; 20: 34-50.
30. Fernandez AF, Esteller M. Viral epigenomes in human tumorigenesis. Oncogene 2010; 29: 1405-1420.
31. Tempera I, Lieberman PM. Chromatin organization of gammaherpesvirus latent genomes. Biochimica et Biophysica Acta 2010; 1799: 236-245.
32. Bloom DC, Giordani NV, Kwiatkowski DL. Epigenetic regulation of latent HSV-1 gene expression. Biochimica et Biophysica Acta 2010; 1799: 246-256.
33. Kristie TM, Liang Y, Vogel JL. Control of alpha-herpesvirus IE gene expression by HCF-1 coupled chromatin modification activities. Biochimica et Biophysica Acta 2010; 1799: 257-265.
34. Pantry SN, Medveczky PG. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Seminars in Cancer Biology 2009; 19: 153-157.
35. Reeves MB. Chromatin-mediated regulation of cytomegalovirus gene expression. Virus Research 2010; in press.
36. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997; 389: 251-260.
37. Davey CA, Sargent DF, Luger K, Maeder AW, Richmond TJ. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution. Journal of Molecular Biology 2002; 319: 1097-1113.
38. Campos EI, Reinberg D. Histones: annotating chromatin. Annual Review of Genetics 2009; 43: 559-599.
39. Woodcock CL, Ghosh RP. Chromatin higher-order structure and dynamics. Cold Spring Harbor Perspectives in Biology 2010; 2: a000596.
40. Clapier CR, Cairns BR. The biology of chromatin remodeling complexes. Annual Review of Biochemistry 2009; 78: 273-304.
41. Korber P, Becker PB. Nucleosome dynamics and epigenetic stability. Essays in Biochemistry 2010; 48: 63-74.
42. Das C, Tyler JK, Churchill ME. The histone shuffle: histone chaperones in an energetic dance. Trends in Biochemical Sciences 2010; 35: 476-489.
43. Ransom M, Dennehey BK, Tyler JK. Chaperoning histones during DNA replication and repair. Cell 2010; 140: 183-195.
44. Corpet A, Almouzni G. Making copies of chromatin: the challenge of nucleosomal organization and epigenetic information. Trends in Cell Biology 2009; 19: 29-41.
45. Talbert PB, Henikoff S. Histone variants-ancient wrap artists of the epigenome. Nature Reviews. Molecular Cell Biology 2010; 11: 264-275.
46. Ray-Gallet D, Almouzni G. Nucleosome dynamics and histone variants. Essays in Biochemistry 2010; 48: 75-87.
47. Dickey JS, Redon CE, Nakamura AJ, Baird BJ, Sedelnikova OA, Bonner WM. H2AX: functional roles and potential applications. Chromosoma 2009; 118: 683-692.
48. Yuan J, Adamski R, Chen J. Focus on histone variant H2AX: to be or not to be. FEBS Letters 2010; 584: 3717-3724.
49. Ahmad K, Henikoff S. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Molecular Cell 2002; 9: 1191-1200.
50. Orsi GA, Couble P, Loppin B. Epigenetic and replacement roles of histone variant H3.3 in reproduction and development. The International Journal of Developmental Biology 2009; 53: 231-243.
51. Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 14075-14080.
52. Wong LH, Ren H, Williams E, et al. Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Research 2009; 19: 404-414.
53. Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 2010; 140: 678-691.
54. Elsaesser SJ, Goldberg AD, Allis CD. New functions for an old variant: no substitute for histone H3.3. Current Opinion in Genetics & Development 2010; 20: 110-117.
55. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705.
56. Kouzarides T, Berger SL. Chromatin modifications and their mechanism of action. In Epigenetics, Allis CD, Jenuwein T, Reinberg D, Caparros M-L (eds). Cold Spring Harbor Laboratory Press: New York, 2007; 191-209.
57. Lee JS, Smith E, Shilatifard A. The language of histone crosstalk. Cell 2010; 142: 682-685.
58. Barth TK, Imhof A. Fast signals and slow marks: the dynamics of histone modifications. Trends in Biochemical Sciences 2010; 35: 618-626.
59. Garcia-Ramirez M, Rocchini C, Ausio J. Modulation of chromatin folding by histone acetylation. The Journal of Biological Chemistry 1995; 270: 17923-17928.
60. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000; 403: 41-45.
61. Bartova E, Krejci J, Harnicarova A, Galiova G, Kozubek S. Histone modifications and nuclear architecture: a review. The Journal of Histochemistry and Cytochemistry 2008; 56: 711-721.
62. Pignatti PF, Cassai E. Analysis of herpes simplex virus nucleoprotein complexes extracted from infected cells. Journal of Virology 1980; 36: 816-828.
63. Oh J, Fraser NW. Temporal Association of the Herpes Simplex Virus (Hsv) Genome with Histone Proteins During a Lytic Infection. Journal of Virology 2008; 82: 3530-3537.
64. Cohen GH, Ponce de Leon M, Diggelmann H, Lawrence WC, Vernon SK, Eisenberg RJ. Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. Journal of Virology 1980; 34: 521-531.
65. Booy FP, Newcomb WW, Trus BL, Brown JC, Baker TS, Steven AC. Liquid-crystalline, phage-like packing of encapsidated DNA in herpes simplex virus. Cell 1991; 64: 1007-1015.
66. Leinbach SS, Summers WC. The structure of herpes simplex virus type 1 DNA as probed by micrococcal nuclease digestion. The Journal of General Virology 1980; 51: 45-59.
67. Groves IJ, Reeves MB, Sinclair JH. Lytic infection of permissive cells with human cytomegalovirus is regulated by an intrinsic 'pre-immediate-early' repression of viral gene expression mediated by histone post-translational modification. The Journal of General Virology 2009; 90: 2364-2374.
68. Varnum SM, Streblow DN, Monroe ME, et al. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. Journal of Virology 2004; 78: 10960-10966.
69. Johannsen E, Luftig M, Chase MR, et al. Proteins of purified Epstein-Barr virus. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 16286-16291.
70. Bechtel JT, Winant RC, Ganem D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. Journal of Virology 2005; 79: 4952-4964.
71. Zhu FX, Chong JM, Wu L, Yuan Y. Virion proteins of Kaposi's sarcoma-associated herpesvirus. Journal of Virology 2005; 79: 800-811.
72. Hall MR, Aghili N, Hall C, Martinez J, St Jeor S. Chromosomal organization of the herpes simplex virus type 2 genome. Virology 1982; 123: 344-356.
73. Loret S, Guay G, Lippe R. Comprehensive characterization of extracellular herpes simplex virus type 1 virions. Journal of Virology 2008; 82: 8605-8618.
74. Lentine AF, Bachenheimer SL. Intracellular organization of herpes simplex virus type 1 DNA assayed by staphylococcal nuclease sensitivity. Virus Research 1990; 16: 275-292.
75. Gibson W, Roizman B. Compartmentalization of spermine and spermidine in the herpes simplex virion. Proceedings of the National Academy of Sciences of the United States of America 1971; 68: 2818-2821.
76. Hougaard DM, Bolund L, Fujiwara K, Larsson LI. Endogenous polyamines are intimately associated with highly condensed chromatin in vivo. A fluorescence cytochemical and immunocytochemical study of spermine and spermidine during the cell cycle and in reactivated nuclei. European Journal of Cell Biology 1987; 44: 151-155.
77. Shaw JE, Levinger LF, Carter CW, Jr. Nucleosomal structure of Epstein-Barr virus DNA in transformed cell lines. Journal of Virology 1979; 29: 657-665.
78. Deshmane SL, Fraser NW. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. Journal of Virology 1989; 63: 943-947.
79. Wensing B, Stuhler A, Jenkins P, Hollyoake M, Karstegl CE, Farrell PJ. Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP. Journal of Virology 2001; 75: 6235-6241.
80. Dyson PJ, Farrell PJ. Chromatin structure of Epstein-Barr virus. The Journal of General Virology 1985; 66: 1931-1940.
81. Stedman W, Deng Z, Lu F, Lieberman PM. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. Journal of Virology 2004; 78: 12566-12575.
82. Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM. Chromatin Remodeling of the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Promoter Correlates with Reactivation from Latency. Journal of Virology 2003; 77: 11425-11435.
83. Nitzsche A, Paulus C, Nevels M. Temporal dynamics of human cytomegalovirus chromatin assembly in productively infected human cells. Journal of Virology 2008; 82:11167-11180.
84. Kent JR, Zeng PY, Atanasiu D, Gardner J, Fraser NW, Berger SL. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. Journal of Virology 2004; 78: 10178-10186.
85. Herrera FJ, Triezenberg SJ. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. Journal of Virology 2004; 78: 9689-9696.
86. Huang J, Kent JR, Placek B, et al. Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. Journal of Virology 2006; 80: 5740-5746.
87. Kutluay SB, Doroghazi J, Roemer ME, Triezenberg SJ. Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology 2008; 373: 239-247.
88. Muggeridge MI, Fraser NW. Chromosomal organization of the herpes simplex virus genome during acute infection of the mouse central nervous system. Journal of Virology 1986; 59: 764-767.
89. Lacasse JJ, Schang LM. During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomes. Journal of Virology 2010; 84: 1920-1933.
90. Jin C, Zang C, Wei G, et al. H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nature Genetics 2009; 41: 941-945.
91. Tachiwana H, Kagawa W, Osakabe A, et al. Structural basis of instability of the nucleosome containing a testis-specific histone variant, human H3T. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 10454-10459.
92. Placek BJ, Harrison LN, Villers BM, Gloss LM. The H2A.Z/H2B dimer is unstable compared to the dimer containing the major H2A isoform. Protein Science 2005; 14: 514-522.
93. Placek BJ, Huang J, Kent JR, et al. The histone variant H3.3 regulates gene expression during lytic infection with herpes simplex virus type 1. Journal of Virology 2009; 83: 1416-1421.
94. Cliffe AR, Knipe DM. Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. Journal of Virology 2008; 82: 12030-12038.
95. Kutluay SB, Triezenberg SJ. Regulation of histone deposition on the herpes simplex virus type 1 genome during lytic infection. Journal of Virology 2009; 83: 5835-5845.
96. Nitzsche A, Winterling C, Mücke K, Paulus C, Nevels M. A unique state of lytic HCMV chromatin maintained by the viral IE1 protein. 4th European Congress of Virology, Cernobbio, Italy, 2010.
97. Wiebusch L, Hagemeier C. Human cytomegalovirus 86-kilodalton IE2 protein blocks cell cycle progression in G(1). Journal of Virology 1999; 73: 9274-9283.
98. Bresnahan WA, Boldogh I, Thompson EA, Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 1996; 224: 150-160.
99. Lu M, Shenk T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. Journal of Virology 1996; 70: 8850-8857.
100. Salvant BS, Fortunato EA, Spector DH. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. Journal of Virology 1998; 72: 3729-3741.
101. Jault FM, Jault JM, Ruchti F, et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. Journal of Virology 1995; 69: 6697-6704.
102. Dittmer D, Mocarski ES. Human cytomegalovirus infection inhibits G1/S transition. Journal of Virology 1997; 71: 1629-1634.
103. Fortunato EA, Sanchez V, Yen JY, Spector DH. Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. Journal of Virology 2002; 76: 5369-5379.
104. Bain M, Sinclair J. The S phase of the cell cycle and its perturbation by human cytomegalovirus. Reviews in Medical Virology 2007; 17: 423-434.
105. Sanchez DH, Spector DH. Subversion of cell cycle regulatory pathways. In Human Cytomegalovirus, Shenk T, Stinski MF (eds). Springer: Berlin, 2008; 243-262.
106. Radsak K, Schmitz B. Unimpaired histone synthesis in human fibroblasts infected by human cytomegalovirus. Medical Microbiology and Immunology 1980; 168: 63-72.
107. Stevens JG, Kado-Boll GJ, Haven CB. Changes in nuclear basic proteins during pseudorabies virus infection. Journal of Virology 1969; 3: 490-497.
108. Yager DR, Bachenheimer SL. Synthesis and metabolism of cellular transcripts in HSV-1 infected cells. Virus Genes 1988; 1: 135-148.
109. Schek N, Bachenheimer SL. Degradation of cellular mRNAs induced by a virion-associated factor during herpes simplex virus infection of Vero cells. Journal of Virology 1985; 55: 601-610.
110. Conn KL, Hendzel MJ, Schang LM. Linker histones are mobilized during infection with herpes simplex virus type 1. Journal of Virology 2008; 82: 8629-8646.
111. Conn K, Hendzel MLS. All core histones (H2A, H2B, H3.3, and H4) are mobilized during infection with herpes simplex virus type I (HSV). 35th Annual International Herpesvirus Workshop, Salt Lake City, USA, 2010.
112. Xue Y, Gibbons R, Yan Z, et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 10635-10640.
113. Tavalai N, Papior P, Rechter S, Stamminger T. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. Journal of Virology 2008; 82: 126-137.
114. Saffert RT, Kalejta RF. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. Journal of Virology 2006; 80: 3863-3871.
115. Cantrell SR, Bresnahan WA. Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. Journal of Virology 2006; 80: 6188-6191.
116. Preston CM, Nicholl MJ. Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. The Journal of General Virology 2006; 87: 1113-1121.
117. Saffert RT, Penkert RR, Kalejta RF. Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells. Journal of Virology 2010; 84: 5594-5604.
118. Saffert RT, Kalejta RF. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro. Journal of Virology 2007; 81: 9109-9120.
119. Cantrell SR, Bresnahan WA. Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication. Journal of Virology 2005; 79: 7792-7802.
120. Lukashchuk V, Everett RD. Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx. Journal of Virology 2010; 84: 4026-4040.
121. Woodhall DL, Groves IJ, Reeves MB, Wilkinson G, Sinclair JH. Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. The Journal of Biological Chemistry 2006; 281: 37652-37660.
122. Kyratsous CA, Silverstein SJ. Components of nuclear domain 10 bodies regulate varicella-zoster virus replication. Journal of Virology 2009; 83: 4262-4274.
123. Tavalai N, Stamminger T. New insights into the role of the subnuclear structure ND10 for viral infection. Biochimica et Biophysica Acta 2008; 1783: 2207-2221.
124. Tavalai N, Stamminger T. Interplay between herpesvirus infection and host defense by PML nuclear bodies. Viruses 2009; 1: 1240-1264.
125. Saffert R, Kalejta R. Promyelocytic leukemia-nuclear body proteins: herpesvirus enemies, accomplices, or both? Future Virol 2008; 3: 265-277.
126. Peng H, Nogueira ML, Vogel JL, Kristie TM. Transcriptional coactivator HCF-1 couples the histone chaperone Asf1b to HSV-1 DNA replication components. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 2461-2466.
127. Luo MH, Rosenke K, Czornak K, Fortunato EA. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)- and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. Journal of Virology 2007; 81: 1934-1950.
128. Wilkinson DE, Weller SK. Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection. Journal of Cell Science 2006; 119: 2695-2703.
129. Placek BJ, Berger SL. The histone variant H2AX is required for the replication of herpes simplex virus genome. 35th Annual International Herpesvirus Workshop, Salt Lake City, USA, 2010.
130. Happel N, Doenecke D. Histone H1 and its isoforms: contribution to chromatin structure and function. Gene 2009; 431: 1-12.
131. Parseghian MH, Newcomb RL, Winokur ST, Hamkalo BA. The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: distribution in human fetal fibroblasts. Chromosome Research 2000; 8: 405-424.
132. Day L, Chau CM, Nebozhyn M, Rennekamp AJ, Showe M, Lieberman PM. Chromatin profiling of Epstein-Barr virus latency control region. Journal of Virology 2007; 81: 6389-6401.
133. Klucher KM, Sommer M, Kadonaga JT, Spector DH. In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. Molecular and Cellular Biology 1993; 13: 1238-1250.
134. MacDonald VE, Howe LJ. Histone acetylation: where to go and how to get there. Epigenetics 2009; 4: 139-143.
135. Dressler GR, Rock DL, Fraser NW. Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. The Journal of General Virology 1987; 68: 1761-1765.
136. Kubat NJ, Tran RK, McAnany P, Bloom DC. Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. Journal of Virology 2004; 78: 1139-1149.
137. Wang QY, Zhou C, Johnson KE, Colgrove RC, Coen DM, Knipe DM. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 16055-16059.
138. Kubat NJ, Amelio AL, Giordani NV, Bloom DC. The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription. Journal of Virology 2004; 78: 12508-12518.
139. Neumann DM, Bhattacharjee PS, Giordani NV, Bloom DC, Hill JM. In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment. Journal of Virology 2007; 81: 13248-13253.
140. Giordani NV, Neumann DM, Kwiatkowski DL, et al. During herpes simplex virus type 1 infection of rabbits, the ability to express the latency-associated transcript increases latent-phase transcription of lytic genes. Journal of Virology 2008; 82: 6056-6060.
141. Dosa R, Burian K, Gonczol E. Human cytomegalovirus latency is associated with the state of differentiation of the host cells: an in vitro model in teratocarcinoma cells. Acta Microbiologica et Immunologica Hungarica 2005; 52: 397-406.
142. Ioudinkova E, Arcangeletti MC, Rynditch A, et al. Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line. Gene 2006; 384: 120-128.
143. Murphy E, Yu D, Grimwood J, et al. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proceedings of the National Academy of Sciences of the United States of America 2003; 100: 14976-14981.
144. Liu XF, Yan S, Abecassis M, Hummel M. Establishment of murine cytomegalovirus latency in vivo is associated with changes in histone modifications and recruitment of transcriptional repressors to the major immediate-early promoter. Journal of Virology 2008; 82: 10922-10931.
145. Liu XF, Yan S, Abecassis M, Hummel M. Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivo. Journal of Virology 2010; 84: 3631-3643.
146. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 4140-4145.
147. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. The Journal of General Virology 2005; 86: 2949-2954.
148. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. Journal of Virology 2005; 79: 11022-11034.
149. Reeves MB, Sinclair JH. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. The Journal of General Virology 2010; 91: 599-604.
150. Niller HH, Wolf H, Minarovits J. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 2008; 41: 298-328.
151. Fernandez AF, Rosales C, Lopez-Nieva P, et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Research 2009; 19: 438-451.
152. Alberter B, Ensser A. Histone modification pattern of the T-cellular Herpesvirus saimiri genome in latency. Journal of Virology 2007; 81: 2524-2530.
153. Gary L, Gilden DH, Cohrs RJ. Epigenetic regulation of varicella-zoster virus open reading frames 62 and 63 in latently infected human trigeminal ganglia. Journal of Virology 2006; 80: 4921-4926.
154. Chau CM, Lieberman PM. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. Journal of Virology 2004; 78: 12308-12319.
155. Chau CM, Zhang XY, McMahon SB, Lieberman PM. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. Journal of Virology 2006; 80: 5723-5732.
156. * and the C promoter of Epstein-Barr virus is unaffected by CpG methylation and does not correlate with Cp activity. The Journal of General Virology 2009; 90: 1183-1189.
157. Amelio AL, McAnany PK, Bloom DC. A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities. Journal of Virology 2006; 80: 2358-2368.
158. Chen Q, Lin L, Smith S, Huang J, Berger SL, Zhou J. CTCF-dependent chromatin boundary element between the latency-associated transcript and ICP0 promoters in the herpes simplex virus type 1 genome. Journal of Virology 2007; 81: 5192-5201.
159. Gunther T, Grundhoff A. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathogens 2010; 6: e1000935.
160. Toth Z, Maglinte DT, Lee SH, et al. Epigenetic Analysis of KSHV Latent and Lytic Genomes. PLoS Pathogens 2010; 6: e1001013.
161. Bernstein BE, Mikkelsen TS, Xie X, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-326.
162. Jenkins PJ, Binne UK, Farrell PJ. Histone acetylation and reactivation of Epstein-Barr virus from latency. Journal of Virology 2000; 74: 710-720.
163. Amelio AL, Giordani NV, Kubat NJ, O'Neil JE, Bloom DC. Deacetylation of the herpes simplex virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICP0 transcriptional permissiveness at early times postexplant. Journal of Virology 2006; 80: 2063-2068.
164. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 850-855.
165. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nature Genetics 2004; 36: 1099-1104.
166. Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC. Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters. PLoS Pathogens 2009; 5: e1000356.
167. Bergbauer M, Kalla M, Schmeinck A, et al. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathogens 2010; 6: e1001114.
168. Nitzsche A, Paulus C, Nevels M. Interfering with human cytomegalovirus replication by manipulating the histone modification pattern of viral chromosomes. 34th Annual International Herpesvirus Workshop, Ithaca, USA, 2009.
169. Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Natural Medicines 2009; 15: 1312-1317.
170. Cuevas-Bennett C, Shenk T. Dynamic histone H3 acetylation and methylation at human cytomegalovirus promoters during replication in fibroblasts. Journal of Virology 2008; 82: 9525-9536.
171. Reeves M, Murphy J, Greaves R, Fairley J, Brehm A, Sinclair J. Autorepression of the human cytomegalovirus major immediate-early promoter/enhancer at late times of infection is mediated by the recruitment of chromatin remodeling enzymes by IE86. Journal of Virology 2006; 80: 9998-10009.
172. Tang Q, Maul GG. Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. Journal of Virology 2003; 77: 1357-1367.
173. Nevels M, Paulus C, Shenk T. Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 17234-17239.
174. Poon AP, Gu H, Roizman B. ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 9993-9998.
175. Walters MS, Kinchington PR, Banfield BW, Silverstein S. Hyperphosphorylation of Histone Deacetylase 2 by Alphaherpesvirus US3 Kinases. Journal of Virology 2010; 84: 9666-9676.
176. Li W, Cun W, Liu L, et al. The transactivating effect of HSV-1 ICP0 is enhanced by its interaction with the PCAF component of histone acetyltransferase. Archives of Virology 2009; 154: 1755-1764.
177. Chen CJ, Deng Z, Kim AY, Blobel GA, Lieberman PM. Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Molecular and Cellular Biology 2001; 21: 476-487.
178. Zhang Y, Jiang Y, Geiser V, Zhou J, Jones C. Bovine herpesvirus 1 immediate-early protein (bICP0) interacts with the histone acetyltransferase p300, which stimulates productive infection and gC promoter activity. The Journal of General Virology 2006; 87: 1843-1851.
179. Kalamvoki M, Roizman B. Circadian CLOCK histone acetyl transferase localizes at ND10 nuclear bodies and enables herpes simplex virus gene expression. Proceedings of the National Academy of Sciences of the United States of America 2010; 107: 17721-17726.
180. Narayanan A, Ruyechan WT, Kristie TM. The coactivator host cell factor-1 mediates Set1 and MLL1 H3K4 trimethylation at herpesvirus immediate early promoters for initiation of infection. Proceedings of the National Academy of Sciences of the United States of America 2007; 104: 10835-10840.
181. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. Journal of Virology 2006; 80: 8006-8018.
182. Lukashchuk V, McFarlane S, Everett RD, Preston CM. Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. Journal of Virology 2008; 82: 12543-12554.
183. Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. Journal of Virology 2006; 80: 7995-8005.
184. Negorev DG, Vladimirova OV, Maul GG. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation. Journal of Virology 2009; 83: 5168-5180.
185. Negorev DG, Vladimirova OV, Ivanov A, Rauscher F, 3rd, Maul GG. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. Journal of Virology 2006; 80: 8019-8029.
186. Everett RD, Parada C, Gripon P, Sirma H, Orr A. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100. Journal of Virology 2008; 82: 2661-2672.
187. Carbone R, Botrugno OA, Ronzoni S, Insinga A, Di Croce L, Pelicci PG, Minucci S. Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein. Molecular and Cellular Biology 2006; 26: 1288-1296.
188. Villa R, Pasini D, Gutierrez A, et al. Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell 2007; 11: 513-525.
189. Wilcox KW, Sheriff S, Isaac A, Taylor JL. SP100B is a repressor of gene expression. Journal of Cellular Biochemistry 2005; 95: 352-365.
190. Seeler JS, Marchio A, Sitterlin D, Transy C, Dejean A. Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 7316-7321.
191. Li H, Leo C, Zhu J, Wu X, O'Neil J, Park EJ, Chen JD. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Molecular and Cellular Biology 2000; 20: 1784-1796.
192. Wu WS, Vallian S, Seto E, et al. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Molecular and Cellular Biology 2001; 21: 2259-2268.
193. Hollenbach AD, McPherson CJ, Mientjes EJ, Iyengar R, Grosveld G. Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. Journal of Cell Science 2002; 115: 3319-3330.
194. Di Croce L, Raker VA, Corsaro M, et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 2002; 295: 1079-1082.
195. Puto LA, Reed JC. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes & Development 2008; 22: 998-1010.
196. Kudoh A, Fujita M, Zhang L, et al. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. The Journal of Biological Chemistry 2005; 280: 8156-8163.
197. Gaspar M, Shenk T. Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proceedings of the National Academy of Sciences of the United States of America 2006; 103: 2821-2826.
198. Tarakanova VL, Leung-Pineda V, Hwang S, et al. Gamma-herpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host & Microbe 2007; 1: 275-286.
199. van Attikum H, Gasser SM. Crosstalk between histone modifications during the DNA damage response. Trends in Cell Biology 2009; 19: 207-217.
200. Mendez-Acuna L, Di Tomaso MV, Palitti F, Martinez-Lopez W. Histone post-translational modifications in DNA damage response. Cytogenetic and Genome Research 2010; 128: 28-36.
201. Chaurushiya MS, Weitzman MD. Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair 2009; 8: 1166-1176.
202. Lilley CE, Chaurushiya MS, Weitzman MD. Chromatin at the intersection of viral infection and DNA damage. Biochimica et Biophysica Acta 2010; 1799: 319-327.
203. Lilley CE, Schwartz RA, Weitzman MD. Using or abusing: viruses and the cellular DNA damage response. Trends in Microbiology 2007; 15: 119-126.
204. Lilley CE, Carson CT, Muotri AR, Gage FH, Weitzman MD. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 5844-5849.
205. Kowalik TF, Pickering MT, Debatis ME, E X, Castillo JP. An E2F1-mediated DNA damage response contributes to HCMV replication. 35th Annual International Herpesvirus Workshop, Salt Lake City, USA, 2010.
206. Chen MR, Chang SJ, Huang H, Chen JY. A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. Journal of Virology 2000; 74: 3093-3104.
207. Baek MC, Krosky PM, He Z, Coen DM. Specific phosphorylation of exogenous protein and peptide substrates by the human cytomegalovirus UL97 protein kinase. Importance of the P+5 position. The Journal of Biological Chemistry 2002; 277: 29593-29599.
208. Ansari A, Emery VC. The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. Journal of Virology 1999; 73: 3284-3291.
209. Daikoku T, Shibata S, Goshima F, Oshima S, Tsurumi T, Yamada H, Yamashita Y, Nishiyama Y. Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2. Virology 1997; 235: 82-93.
210. Upton JW, van Dyk LF, Speck SH. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks. Virology 2005; 341: 271-283.
211. Godden-Kent D, Talbot SJ, Boshoff C, et al. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate theretinoblastoma protein and histone H1. Journal of Virology 1997; 71: 4193-4198.
212. Li M, Lee H, Yoon DW, et al. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. Journal of Virology 1997; 71: 1984-1991.
213. Kaldis P. The N-terminal peptide of the Kaposi's sarcoma-associated herpesvirus (KSHV)-cyclin determines substrate specificity. The Journal of Biological Chemistry 2005; 280: 11165-11174.
214. Lilley CE, Chaurushiya MS, Boutell C, et al. A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses. The EMBO Journal 2010; 29: 943-955.
215. Musolino C, Sant'antonio E, Penna G, et al. Epigenetic therapy in myelodysplastic syndromes. European Journal of Haematology 2010; 84: 463-473.
216. Muller A, Florek M. 5-Azacytidine/Azacitidine. Recent Results in Cancer Research 2010; 184: 159-170.
217. Daskalakis M, Blagitko-Dorfs N, Hackanson B. Decitabine. Recent Results in Cancer Research 2010; 184: 131-157.
218. Hymes KB. The role of histone deacetylase inhibitors in the treatment of patients with cutaneous T-cell lymphoma. Clinical Lymphoma, Myeloma & Leukemia 2010; 10: 98-109.
219. Monti B, Polazzi E, Contestabile A. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Current Molecular Pharmacology 2009; 2: 95-109.
220. Dekker FJ, Haisma HJ. Histone acetyl transferases as emerging drug targets. Drug Discovery Today 2009; 14: 942-948.
221. Selvi RB, Kundu TK. Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics. Biotechnology Journal 2009; 4: 375-390.
222. Cole PA. Chemical probes for histone-modifying enzymes. Nature Chemical Biology 2008; 4: 590-597.
223. Balasubramanyam K, Varier RA, Altaf M, et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. The Journal of Biological Chemistry 2004; 279: 51163-51171.
224. Epstein JA. Currying favor for the heart. Journal of Clinical Investigation 2008; 118: 850-852.
225. Morimoto T, Sunagawa Y, Kawamura T, et al. The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. Journal of Clinical Investigation 2008; 118: 868-878.
226. Hergenhahn M, Soto U, Weninger A, et al. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Molecular Carcinogenesis 2002; 33: 137-145.
227. Kondo A, Morimoto T, Okazaki K. Detection of antitumor promoting activity in Raji cells carrying Epstein-Barr virus genome by immunoblotting analysis. Bioscience, Biotechnology, and Biochemistry 1998; 62: 377-379.
228. Ranjan D, Siquijor A, Johnston TD, Wu G, Nagabhuskahn M. The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. The American Surgeon 1998; 64: 47-51; discussion 51-42.
229. Chen C, Johnston TD, Jeon H, et al. An in vitro study of liposomal curcumin: stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. International Journal of Pharmaceutics 2009; 366: 133-139.
230. Singh RK, Rai D, Yadav D, Bhargava A, Balzarini J, De Clercq E. Synthesis, antibacterial and antiviral properties of curcumin bioconjugates bearing dipeptide, fatty acids and folic acid. European Journal of Medicinal Chemistry 2010; 45: 1078-1086.
231. Rai D, Yadav D, Balzarini J, De Clercq E, Singh RK. Design and development of curcumin bioconjugates as antiviral agents. Nucleic Acids Symposium Series (Oxford) 2008; 52: 599-600.
232. Bourne KZ, Bourne N, Reising SF, Stanberry LR. Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral Research 1999; 42: 219-226.
233. Kutluay SB, DeVos SL, Klomp JE, Triezenberg SJ. Transcriptional coactivators are not required for herpes simplex virus type 1 immediate-early gene expression in vitro. Journal of Virology 2009; 83: 3436-3449.
234. Kallin B, Luka J, Klein G. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. Journal of Virology 1979; 32: 710-716.
235. Luka J, Kallin B, Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 1979; 94: 228-231.
236. Greenberger JS, Karpas A, Gans PJ, Neumann H, Moloney WC. Increased myeloid-associated enzymes in Epstein-Barr virus nuclear antigen-positive human cell lines exposed to butyric acid in vitro. Blood 1978; 51: 1073-1085.
237. Michaelis M, Suhan T, Reinisch A, et al. Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition. Investigative Ophthalmology & Visual Science 2005; 46: 3451-3457.
238. Poon AP, Liang Y, Roizman B. Herpes simplex virus 1 gene expression is accelerated by inhibitors of histone deacetylases in rabbit skin cells infected with a mutant carrying a cDNA copy of the infected-cell protein no. 0. Journal of Virology 2003; 77: 12671-12678.
239. Pinnoji RC, Bedadala GR, George B, Holland TC, Hill JM, Hsia SC. Repressor element-1 silencing transcription factor/neuronal restrictive silencer factor (REST/NRSF) can regulate HSV-1 immediate-early transcription via histone modification. Virology Journal 2007; 4: 56.
240. Danaher RJ, Jacob RJ, Steiner MR, Allen WR, Hill JM, Miller CS. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. Journal of Neurovirology 2005; 11: 306-317.
241. Otsuki A, Patel A, Kasai K, et al. Histone deacetylase inhibitors augment antitumor efficacy of herpes-based oncolytic viruses. Molecular Therapy 2008; 16: 1546-1555.
242. Tanaka J, Sadanari H, Sato H, Fukuda S. Sodium butyrate-inducible replication of human cytomegalovirus in a human epithelial cell line. Virology 1991; 185: 271-280.
243. Radsak K, Fuhrmann R, Franke RP, Schneider D, Kollert A, Brucher KH, Drenckhahn D. Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells. Archives of Virology 1989; 107: 151-158.
244. Kuntz-Simon G, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication. The Journal of General Virology 1995; 76: 1409-1415.
245. Clement C, Bhattacharjee PS, Kumar M, Foster TP, Thompson H, Hill JM. Upregulation of mouse genes in HSV-1 latent TG after butyrate treatment implicates the multiple roles of the LAT-ICP0 locus. Investigative Ophthalmology & Visual Science 2011; 52: 1770-1779.
246. Avila MA, Garcia-Trevijano ER, Lu SC, Corrales FJ, Mato JM. Methylthioadenosine. The International Journal of Biochemistry & Cell Biology 2004; 36: 2125-2130.
247. Nagy PL, Griesenbeck J, Kornberg RD, Cleary ML. A trithorax-group complex purified from Saccharomyces cerevisiae is required for methylation of histone H3. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 90-94.
248. Wysocka J, Herr W. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends in Biochemical Sciences 2003; 28: 294-304.
249. Shi Y, Lan F, Matson C, et al. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 2004; 119: 941-953.
250. Culhane JC, Cole PA. LSD1 and the chemistry of histone demethylation. Current Opinion in Chemical Biology 2007; 11: 561-568.
251. Agger K, Christensen J, Cloos PA, Helin K. The emerging functions of histone demethylases. Current Opinion in Genetics & Development 2008; 18: 159-168.
252. Luciano RL, Wilson AC. An activation domain in the C-terminal subunit of HCF-1 is important for transactivation by VP16 and LZIP. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 13403-13408.
253. Narayanan A, Nogueira ML, Ruyechan WT, Kristie TM. Combinatorial transcription of herpes simplex virus and varicella zoster virus immediate early genes is strictly determined by the cellular coactivator HCF-1. The Journal of Biological Chemistry 2005; 280: 1369-1375.
254. Taylor TJ, Knipe DM. Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins withICP8. Journal of Virology 2004; 78: 5856-5866.
255. Everett RD, Murray J, Orr A, Preston CM. Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts. Journal of Virology 2007; 81: 10991-11004.
256. van Leeuwen H, Okuwaki M, Hong R, Chakravarti D, Nagata K, O'Hare P. Herpes simplex virus type 1 tegument protein VP22 interacts with TAF-I proteins and inhibits nucleosome assembly but not regulation of histone acetylation by INHAT. The Journal of General Virology 2003; 84: 2501-2510.
257. Terhune SS, Moorman NJ, Cristea IM, et al. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. PLoS Pathogens 2010; 6: e1000965.
258. Reeves M, Woodhall D, Compton T, Sinclair J. Human cytomegalovirus IE72 protein interacts with the transcriptional repressor hDaxx to regulate LUNA gene expression during lytic infection. Journal of Virology 2010; 84: 7185-7194.
259. Lee SB, Ou DS, Lee CF, Juan LJ. Gene-specific transcriptional activation mediated by the p150 subunit of the chromatin assembly factor 1. The Journal of Biological Chemistry 2009; 284: 14040-14049.
260. Sarek G, Jarviluoma A, Moore HM, et al. Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency. PLoS Pathogens 2010; 6: e1000818.
261. Sourvinos G, Tavalai N, Berndt A, Spandidos DA, Stamminger T. Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. Journal of Virology 2007; 81: 10123-10136.
262. Sourvinos G, Everett RD. Visualization of parental HSV-1 genomes and replication compartments in association with ND10 in live infected cells. The EMBO Journal 2002; 21: 4989-4997.
263. Krauss S, Kaps J, Czech N, Paulus C, Nevels M. Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2. Journal of Virology 2009; 83: 12854-12870.
264. Bouvier G, Hergenhahn M, Polack A, Bornkamm GW, Bartsch H. Validation of two test systems for detecting tumor promoters and EBV inducers: comparative responses of several agents in DR-CAT Raji cells and in human granulocytes. Carcinogenesis 1993; 14: 1573-1578.
265. Kobiler O, Lipman Y, Therkelsen K, Daubechies I, Enquist LW. Herpesviruses carrying a Brainbow cassette reveal replication and expression of limited numbers of incoming genomes. Nature Communications 2010; 1: 146.
266. Chang PC, Fitzgerald LD, Hsia DA, et al. Histone demethylase JMJD2A regulates KSHV replication and is targeted by a viral transcriptional factor. Journal of Virology 2011; 85: 3283-3293.